Trials / Completed
CompletedNCT05041413
Helping Moms Quit Pilot Trial
Enhancing the Delivery of Tobacco Treatment During Pregnancy and Postpartum Though Systems-Change
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Kansas Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to test the feasibility and preliminary effectiveness of a tailored text message program to support smoking abstinence among postpartum women who smoke or recently quit.
Detailed description
This pilot trial will evaluate a text message intervention (Moms Quit) to be initiated with postpartum women within one month of delivery. Moms Quit is a tailored program to support smoking abstinence among new mothers who are either current smokers or quit during their most recent pregnancy. Investigators will randomize 30 postpartum women, stratified by recent/current smoking status, into Moms Quit versus vs. CONTROL. Investigators hypothesize that participants receiving Moms Quit will have, on average, a significantly longer period of self-reported prolonged abstinence compared to CONTROL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Moms Quit | Participants will receive text messages tailored on (1) current smoking status and (2) intention to quit/remain quit. Message content includes supportive messaging for child and self-care, relapse prevention, and smoking cessation. Women who are ready to quit will receive messages from the SmokeFreeText library. |
| BEHAVIORAL | Text4Baby | Text4Baby is a free, publicly available text messaging program that provides information about nutrition, safe sleep tips, baby's milestones, signs and symptoms of labor, doctor visit and appointment reminders, breastfeeding advice, car seat safety, information on health insurance, urgent health alerts, and resource hotlines and websites. |
Timeline
- Start date
- 2021-08-11
- Primary completion
- 2022-10-05
- Completion
- 2022-10-05
- First posted
- 2021-09-13
- Last updated
- 2022-11-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05041413. Inclusion in this directory is not an endorsement.